Tesofensine Better Than Reductil
Written by Jane Tucker | Thursday, 23 October 2008 | There are 2 comments
As always, the best medical discoveries always come about by accident! A team of researchers who had originally focused on trying to treat both Alzheimer's and Parkinson's diseases stumbled across an interesting side effect in clinical testing which was loss of appetite.

The drug in question namely tesofensine, appears to be extremely effective in reducing hunger pangs which obese people who are attempting to lose weight suffer from. The researchers claim that when combined with proper diet it is possible to lose up to 1/5 of overall body weight in six months.
Tesofensine which was developed by Neurosearch, a Danish organisation got in touch with Professor Arne Astrup from the University of Copenhagen to conduct clinical testing on this drug from a weight loss perspective when its appetite suppressant properties started to become apparent.
The clinical testing which involved 161 obese individuals showed that those people who used it experienced significantly more weight loss than those who were handed a placebo. Professor Astrup said that the sort of weight loss associated with Tesofensine was comparable to that of those people given gastric bypass surgery, and about twice the weight loss associated with other weight loss medications like Reductil, Acomplia and Xenical.
It should be remembered however that Tesofensine works in exactly the same way as Reductil and therefore is not some new scientific breakthrough in terms of appetite suppressant medication but merely possibly a more effective version. As the testing has only been done on a small amount of patients the effectiveness of Tesofensine cannot be definitely confirmed and it will need to be examined with much more rigorous clinical testing to check for side effects.
Nevertheless Tesofensine could be a weight loss medication of the future which may help obese men and women rid themselves of the terrible scourge of obesity that is plaguing wealthy countries all over the world.


